Detailed entry information

Protein Information (annotations from UniProt)

Database IDHIV0002033
UniProt IDQ7Z3B4
Primary gene name(s)NUP54
Synonym gene name(s)unknown
Protein nameNucleoporin p54
Protein functionComponent of the nuclear pore complex, a complex required for the trafficking across the nuclear membrane. {ECO:0000250|UniProtKB:P70582}.
Subcellular locationNucleus, nuclear pore complex {ECO:0000250|UniProtKB:P70582}. Nucleus membrane {ECO:0000250|UniProtKB:P70582};
Peripheral membrane protein {ECO:0000250|UniProtKB:P70582};
Cytoplasmic side {ECO:0000250|UniProtKB:P70582}. Nucleus membrane {ECO:0000250|UniProtKB:P70582};
Peripheral membrane protein {ECO:0000250|UniProtKB:P70582};
Nucleoplasmic side {ECO:0000250|UniProtKB:P70582}. Note=Biased towards cytoplasmic side. Central region of the nuclear pore complex, within the transporter. {ECO:0000250|UniProtKB:P70582}.
ECO codeClick here for more information.
Amino acid sequence
FASTA format: Q7Z3B4
Gene Ontology
(Biological Process)
Complete annatation
gene silencing by RNA [GO:0031047];
intracellular transport of virus [GO:0075733];
mitotic nuclear envelope disassembly [GO:0007077];
mRNA export from nucleus [GO:0006406];
NLS-bearing protein import into nucleus [GO:0006607];
nuclear pore organization [GO:0006999];
protein heterotetramerization [GO:0051290];
protein heterotrimerization [GO:0070208];
protein homooligomerization [GO:0051260];
protein sumoylation [GO:0016925];
protein targeting to nuclear inner membrane [GO:0036228];
regulation of cellular response to heat [GO:1900034];
regulation of glucose transport [GO:0010827];
regulation of protein import into nucleus [GO:0042306];
tRNA export from nucleus [GO:0006409];
viral process [GO:0016032];
viral transcription [GO:0019083]
Gene Ontology
(Molecular Function)
Complete annatation
nucleocytoplasmic transporter activity [GO:0005487];
structural constituent of nuclear pore [GO:0017056]
Gene Ontology
(Cellular Component)
Complete annatation
nuclear envelope [GO:0005635];
nuclear membrane [GO:0031965];
nuclear pore central transport channel [GO:0044613]
Protein-protein interaction119759
Phylogenetic treeQ7Z3B4
HIV replication factor status Zhou et al., Cell. Host. Microbe., 2008
Brass et al., Science, 2008
Smith et al., J. Immunol, 2010
gene status
Lu et al., J. Virol., 2011
      Folds changes 8h: unknown; Folds changes 16h: unknown; Tested: unknown;
Schoggins JW and Rice CM, Curr. Opin. Virol., 2011
      Targeted viruses: unknown
      Viral life cycle: unknown
      Mechanism related to antiviral activity: unknown
Anti-viral restriction factor Liu et al., Retrovirology, 2011
      unknown (Triplicates)

Gene Expression Profile       top

            Up-regulated;            Down-regulated

For brief introduction to each study, please go to the help page.

Gene expression during HIV latency

(1). Mohammadi et al., PLoS Pathog., 2014

Differentially expressed transcripts (Pairwise) during latency and subsequent viral reactivation using several agents - Primary CD4+ T-cell based model

DMSO: Dimethyl suloxyde (negative control) - 0.0033% final
SAHA: Vorinostat (Histone deacetylase inhibitor) - 0.5 μM
CD3: TCR Stimulation by IL-2+ antiCD3/anti-CD28 antibodies
IL7: Interleukin-7 based stimulation
DISU: Disulfiram (alcohol dehydrogenase inhibitor) - 0.5 μM
AZA: 5-azacytidine (AZA; DNA methylation inhibitor) - 1 μM
Experimental Condition Log2 Fold Change P value Adjusted P value
AZA vs. CD31.220021236475750.0002399784645397140.00104144987548015
AZA vs. DISU0.09323392261037120.7132426505160630.973233942294547
AZA vs. IL70.1791526497276570.3538938622804810.999311006273513
AZA vs. SAHA0.08184125343692310.738416630489670.927265822896219
DISU vs. CD3-1.139760645949860.001881585377781940.00711560252232569
DISU vs. IL70.07726731165998640.7596743407592460.942791692347545
DISU vs. SAHA-0.01070461150541590.9708599013333250.994753523216707
DMSO vs. AZA-0.09798735756754520.5618731464369151
DMSO vs. CD3-1.32973155617414.3725832052699e-050.000215130522493112
DMSO vs. DISU-0.1932252677314260.4301877131415780.881718877024027
DMSO vs. IL70.2845374453814820.1157643595013090.604694289494885
DMSO vs. SAHA0.1727651488526040.4655379232231820.792443844769281
HIV vs. Mock in Activation-0.2760150060278940.6572430228486840.999983755607037
HIV vs. Mock in Latency0.01845264455799510.9115191887199780.999834320637052
IL7 vs. CD3-1.032010291271810.001474139745021420.00592999956677551
SAHA vs. CD3-1.163612812973680.001195954263656260.00416524861412061
SAHA vs. IL7-0.1012770664566780.6786379665893470.847819385742401
(2). Iglesias-Ussel et al., J. Virol., 2013

Up and Downregulated transcripts during Latency (Latently infected CD4+ T cells vs Uninfected)- Primary CD4+Tcell based model
Log2 Fold Change P Value
unknown unknown

Gene expression during HIV infection and replication

(1). Imbeault et al., PloS Pathog., 2012

Transcriptomic profiling of HIV-1 infected CD4+ T cells - Primary CD4+ T cells
Experiment type Log2 Fold Change P Value Adjusted P Value
Infected vs. Mock unknown unknown unknown
Infected vs. Bystander unknown unknown unknown
(2). Lefebvre et al., J. Virol., 2011

Transcriptome analysis of T-cell line (Sup T1)
Log2 Fold Change unknown
(3). Li et al., J. Immunol., 2013

Lymphatic tissue
Acute Fold Change Acute P Value Asymt Fold Change Asypt P Value AIDS Fold Change AIDS P Value
unknown unknown unknown unknown unknown unknown
(4). Chang et al., MBio., 2011

Transcriptome analysis of T-cell line (Sup T1)

Derived from Sherrill-Mix et al., BMC Retrovirol., 2015 cross validation
Up-regulated (True) FALSE
(5). Sherrill-Mix et al., BMC Retrovirol., 2015

Deep RNA-seq analysis of primary human T cell infected with low passage HIV isolate HIV89.6 - Primary CD4+ T cell based
Test Status Log2 Fold Change P Value
OK 0.204006 0.162745
(6). Rotger et al., PLoS Pathog., 2010

Genome-wide mRNA expression of CD4+ T cells from HIV-infected patient
(Genes differentially expressed (at adjusted p<0.01) according to the empirical Bayes approach)
Log2 Fold Change P Value
unknown unknown

Proteomic/Transcriptomics studies indicating differentially expressed genes mediated by HIV

(1). Greenwood et al., Elife, 2016

Activated (CD3/CD28) Primary human CD4+ T cells infected with pNL4-3-dE-EGFP. The table shows the complete (unfiltered) TMT (tandem mass tag)-based proteomic time course dataset
6 h 24 h 48 h 72 h RTi
1.026 0.859 0.935 0.88 0.789
(2). Navare et al., Virology, 2012

SUP-T1 cell line
FC-4hpi P-value FC-8hpi P-value FC-20hpi P-value Category
unknown unknown unknown unknown unknown unknown unknown
(3). Hyrcza et al., J. Virolo., 2007

Primary human CD4+ and CD8+ T Cells
Affymetrix Prob ID Fold Change In CD8? Category
unknown unknown unknown unknown

Protein Overview       top

Drug-protein Interaction       (annotations from DrugBank)      top

not found

Protein Secondary Structure       (annotations from PDB)      top

PDB Accession Method Resolution Chain Structure Preview
4JNU X-ray 1.4Å A/B/C/D=453-491.
4JNV X-ray 1.8Å A/B/C/D=453-491.
4JO7 X-ray 1.7Å B/D/F/H=453-491.
4JO9 X-ray 2.5Å A/C=453-491.
5IJN EM 21.4Å F/L/R/X=1-507.
5IJO EM 21.4Å F/L/R/X=1-507.

HIV-1 Interaction       (annotations from NCBI HIV-1 Interaction Database)      top

HIV Partner Interaction Type PubMed
Vpr binds 9582382

Metabolic/Signalling Pathway       (annotations from KEGG database)      top

Pathway Accession Number Description
hsa03013 RNA transport - Homo sapiens (human)